about
Tibetan medicine "RNSP" in treatment of Alzheimer diseaseKinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving groupRivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsFrom single target to multitarget/network therapeutics in Alzheimer's therapyNeuroprotective effects of donepezil against cholinergic depletion.Dysfunctional Presynaptic M2 Receptors in the Presence of Chronically High Acetylcholine Levels: Data from the PRiMA Knockout Mouse.Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease modelAlzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.Midlife predictors of Alzheimer's disease.Drosophila melanogaster in the study of human neurodegeneration.Unveiling molecular events in the brain by noninvasive imaging.Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex.Modes and models of forebrain cholinergic neuromodulation of cognition.Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-AmyloidRecent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.The ethics of elective psychopharmacologyGalantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in ratsGalantamine protects against lipopolysaccharide-induced acute lung injury in rats.Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking studyDonepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.Subregional neuroanatomical change as a biomarker for Alzheimer's disease.Emerging cognitive enhancing drugs.Treatment initiatives for patients with Alzheimer's disease.Combination treatments in Alzheimer's disease: risks and benefits.Acetylcholinesterase inhibitors: a patent review (2008 - present).New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Water Extractable Phytochemicals from Peppers (Capsicum spp.) Inhibit Acetylcholinesterase and Butyrylcholinesterase Activities and Prooxidants Induced Lipid Peroxidation in Rat Brain In Vitro.Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25-35-impaired mouse cognitive function.Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects.Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.Rivastigmine patch reduces the incidence of postoperative delirium in older patients with cognitive impairment.Cardiovascular dementia - a different perspective.Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study.It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.Concurrent administration of thyroxine and donepezil induces plastic changes in the prefrontal cortex of adult hypothyroid rats.Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors.Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives.
P2860
Q26765304-80E0982E-1EE3-4D08-8E83-F52C9C9FFF49Q27677846-ED7DE2ED-C097-4CF0-8FEB-D97679D50497Q28479242-216232CD-2B2E-488A-AA18-5D85B238ACCEQ28658200-9F2EDCBD-9936-4E6A-820A-BB9D6B2D0083Q30440321-4741CB0D-CCBA-446C-AFBE-98D12E93D917Q31011918-824DBF32-A424-4754-A76B-010316C91E9BQ33605826-93FB60D4-14E8-437F-B111-97D5983A86C8Q33736582-C6A017C2-3620-47D0-AA9F-98DEBCA1EE81Q33956934-BB4B9530-BCDE-478F-AFAA-22489BB069A8Q34022667-C3F27A48-EF1A-40B3-8B65-237741C3D8A9Q34046040-F4AA6721-F7F6-4FEE-9359-D9904062801BQ34249489-0493430A-589D-4786-99CE-7510F108C836Q34355481-0F347B19-8D10-4FAA-93CF-F993899D4678Q35130541-392B1550-7F28-4499-8B9D-E59B24A9F406Q35199867-2914D459-5657-453F-91A2-AA301E516FF1Q35210180-219DCB06-CC6D-4B4B-B4F3-2B960FADADDAQ35617556-D501B63E-A02F-4644-8F25-4B316E56B057Q35886546-4C2778E1-2F8A-4455-9701-6F2BB85662D1Q36174102-769ED43B-70ED-4844-A83B-BD08C1EF0533Q36461300-1F29382E-835B-4F97-821E-B7C2D54BE98CQ37161493-D02D47BD-3802-4FCF-BBC6-65E5B8E988FFQ37282357-CB4CF2DD-E519-4B32-8927-AD8AA819F696Q37469614-13B96358-4959-49CC-9977-FF16558B3303Q37601479-EAC80151-0927-487B-86B5-AD465E990D7DQ37667954-C01EB35B-AA1E-4F43-9A55-C94BAC7F413BQ37737293-14ECC68D-E3A2-4951-ACA8-076E7F92BA37Q38024391-7EB2CEB4-B97A-40AA-B712-D963629ABCE5Q38099889-EC64D4D7-DB49-412B-8B6D-CA6FA16D12CCQ38284940-8679C76A-3AEF-446A-97B6-7BBC3CF20BA2Q38534395-13DCAED5-2F43-4651-A93C-744F2E92361EQ38820531-9A8AEA13-1C34-4378-8185-B8C8407FF049Q39040746-53D68C23-4341-48F1-8FFC-959BE988DFB3Q39154022-89476107-FB0D-400A-9EE7-CCE1955A2A27Q39453759-23BBBC4D-5893-4F7B-8AAB-92EDEE41C7AAQ40361355-B8C53AE8-19FB-4B3F-8325-3779802800ACQ41506738-4605757C-BBA0-4022-B629-0C56ABC03EE5Q42149357-FDC46F7B-CA70-4676-8B8E-6E342DDF3F97Q42546587-D0C6D4EE-1763-4A75-A0B6-C728793D7531Q42800185-3B102A44-F6F7-4B8D-9D0A-D28BC5002287Q42804221-1A72EE92-51B3-4519-840B-998C40352BC5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cholinesterase inhibitors and beyond.
@en
Cholinesterase inhibitors and beyond.
@nl
type
label
Cholinesterase inhibitors and beyond.
@en
Cholinesterase inhibitors and beyond.
@nl
prefLabel
Cholinesterase inhibitors and beyond.
@en
Cholinesterase inhibitors and beyond.
@nl
P1476
Cholinesterase inhibitors and beyond.
@en
P2093
Giancarlo Pepeu
Maria Grazia Giovannini
P356
10.2174/156720509787602861
P577
2009-04-01T00:00:00Z